Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors

NCT00225121 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
121
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer